EF
LTRN icon

Entrust Financial’s Lantern Pharma LTRN Stock Holding History

Entrust Financial’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08K Buy
+500
New +$1.47K ﹤0.01% 406

Other funds holding LTRN

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

Entrust Financial's LTRN Position: Q2 2026 in Review

Entrust Financial opened a new position in Lantern Pharma (LTRN) in Q2 2026: 500 shares worth $2.08K. The stake represents ﹤0.01% of the portfolio and ranks #406 among its holdings.

4 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • Entrust Financial held 500 shares of Lantern Pharma worth $2.08K as of Q2 2026.
  • Lantern Pharma was a new Entrust Financial position in Q2 2026.
  • Lantern Pharma made up ﹤0.01% of Entrust Financial's portfolio in Q2 2026, its #406 holding.
  • 4 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Entrust Financial's 13F filing for Q2 2026, filed 20 Jul 2026.